Literature DB >> 1591017

The role of basic fibroblast growth factor in skeletal muscle regeneration.

M Guthridge1, M Wilson, J Cowling, J Bertolini, M T Hearn.   

Abstract

Muscle growth and regeneration is controlled by locally produced growth factors which activate satellite cells and stimulate their proliferation, differentiation and fusion to form mature myotubes. Basic fibroblast growth factor (bFGF) has been previously shown to promote proliferation and inhibit differentiation of myoblasts in vitro. In comparison, the in vivo role of this growth factor is less well documented. In the present investigation on the role of bFGF in muscle regeneration, bFGF mRNA levels were studied in two experimental systems: (1) primary cell cultures derived from rat skeletal muscles, and (2) an in vivo rat muscle injury model. bFGF mRNA was detected in myoblasts just prior to fusion and in myotubes of primary muscle cell cultures. In the non-injured muscle, bFGF mRNA transcripts were detected in myotubes but not satellite cells. In the in vivo muscle injury model bFGF mRNA was observed in myoblasts and in degenerating and regenerated myotubes. The significance of these experimental results in terms of the role played by bFGF in the myogenic program in vivo are discussed.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1591017     DOI: 10.3109/08977199209008871

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  16 in total

1.  Dual-channel laser scanning microscopy for the identification and quantification of proliferating skeletal muscle satellite cells following synergist ablation.

Authors:  D Brotchie; I Davies; G Ireland; M Mahon
Journal:  J Anat       Date:  1995-02       Impact factor: 2.610

Review 2.  Developmental origins of fusion-negative rhabdomyosarcomas.

Authors:  Ken Kikuchi; Brian P Rubin; Charles Keller
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

Review 3.  Inclusion body myositis.

Authors:  M J Garlepp; F L Mastaglia
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

Review 4.  Strategies to improve regeneration of the soft palate muscles after cleft palate repair.

Authors:  Paola L Carvajal Monroy; Sander Grefte; Anne Marie Kuijpers-Jagtman; Frank A D T G Wagener; Johannes W Von den Hoff
Journal:  Tissue Eng Part B Rev       Date:  2012-07-19       Impact factor: 6.389

5.  Permanent myopathy caused by mutation of SCN4A Metl592Val: Observation on myogenesis in vitro and on effect of basic fibroblast growth factor on the muscle.

Authors:  Yu Feng; Hong Wang; Xiao-Guang Luo; Yan Ren
Journal:  Neurosci Bull       Date:  2009-04       Impact factor: 5.203

6.  1,25(OH)(2)vitamin D(3) enhances myogenic differentiation by modulating the expression of key angiogenic growth factors and angiogenic inhibitors in C(2)C(12) skeletal muscle cells.

Authors:  Leah A Garcia; Monica G Ferrini; Keith C Norris; Jorge N Artaza
Journal:  J Steroid Biochem Mol Biol       Date:  2012-09-12       Impact factor: 4.292

7.  Lysophosphatidic acid and bFGF control different modes in proliferating myoblasts.

Authors:  S Yoshida; A Fujisawa-Sehara; T Taki; K Arai; Y Nabeshima
Journal:  J Cell Biol       Date:  1996-01       Impact factor: 10.539

8.  Effect of Source Animal Age upon Macrophage Response to Extracellular Matrix Biomaterials.

Authors:  Samuel T LoPresti; Bryan N Brown
Journal:  J Immunol Regen Med       Date:  2018-04-25

9.  A prosurvival and proangiogenic stem cell delivery system to promote ischemic limb regeneration.

Authors:  Yanyi Xu; Minghuan Fu; Zhihong Li; Zhaobo Fan; Xiaofei Li; Ying Liu; Peter M Anderson; Xiaoyun Xie; Zhenguo Liu; Jianjun Guan
Journal:  Acta Biomater       Date:  2015-12-12       Impact factor: 8.947

10.  Tumour formation by single fibroblast growth factor receptor 3-positive rhabdomyosarcoma-initiating cells.

Authors:  M Hirotsu; T Setoguchi; Y Matsunoshita; H Sasaki; H Nagao; H Gao; K Sugimura; S Komiya
Journal:  Br J Cancer       Date:  2009-11-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.